Diseases, Conditions, Syndromes

Researchers develop decision-making tool to benefit patients with HCV

An estimated 3.5 million people in the United States have chronic hepatitis C (HCV), according to the Centers for Disease Control and Prevention. It is the most common cause for cirrhosis and liver cancer in the United States ...

Diabetes

Pioglitazone has limited effect in lipoatrophic diabetes

(HealthDay)—Pioglitazone may not be effective for lowering blood glucose levels, although it is associated with slight improvement in liver function, in lipoatrophic diabetes induced by juvenile dermatomyositis, according ...

Diseases, Conditions, Syndromes

Scientists reverse mechanism of fatty liver disease

Researchers have identified the mechanism which causes a build-up of fat in the liver in a disease affecting one in five in the UK—and were able to reverse it in a mouse model.

page 3 from 10